Truly-Empty AAV Particles

Volume Size Total Viral Particle(VP) Price($) 100 ul 1X10^12 299 200 ul 2X10^12 499 500 ul 5X10^12 999 1000 ul 10X10^12 1799   Truly-empty AAV particles  devoid of any genomic materials, which is different with byproduct-empty AAV particles.  They serve…

Truly-Empty AAV Particles

$299.00$1,799.00

Volume Size Total Viral Particle(VP) Price($)
100 ul 1X10^12 299
200 ul 2X10^12 499
500 ul 5X10^12 999
1000 ul 10X10^12 1799

 

Truly-empty AAV particles  devoid of any genomic materials, which is different with byproduct-empty AAV particles.  They serve as valuable tools for various stages of gene therapy development and characterization

Premade serotypes include AAV1, AAV2, AAV2retro AAV3B, AAV5, AAV6, AAV7, AAV8, AAV9, AAV10, AAV11, AAV12, AAV13, AAVDJ, AAVrh.10, and AAVrh74. For any other AAV serotypes or variants, please contact us. We can produce them within 2 weeks.

Titer: 1.0×1013 VP/ml (VP: Viral Particle).

Purification: Two rounds of CsCl ultracentrifuge.

Buffer: 0.001% F-68/DPBS with additional 150mM NaCl.

Storage:  -80°C for long term (> 1 year);  -20°C for short term(1-2 months);  4 °C for 1-2 weeks.

Shipping: Dry ice.

Add To Quote
SKU: N/A Category:

Description

Truly empty capsids  devoid of any genomic materials.  They serve as valuable tools for various stages of gene therapy development and characterization.

  1. Reference Materials: Well-characterized empty AAV capsids, can serve as standardized reference materials for analytical assays.
  2. Quality Control: During the manufacturing process of AAV vectors, using well-characterized capsids as reference materials allows manufacturers to monitor and ensure the quality, purity, and consistency of their AAV products.
  3. Biodistribution Studies: Empty AAV  can be used in biodistribution studies to assess how different capsids distribute in various tissues after administration.
  4. Immunogenicity Assessment: By exposing the immune system to well-characterized AAV capsids, researchers can evaluate the immune responses induced by specific serotypes..
  5. Comparative Studies: Empty AAV  allow researchers to compare the characteristics of different AAV serotypes without the confounding effects of transgene expression.
  6. Process Development: Empty  AAV  can be used in the development and optimization of manufacturing processes for AAV vectors.
  7. Assay Development: Empty  AAV capsids serve as positive controls in various assays, aiding the development of new methods for AAV characterization, stability testing, and potency determination.
  8. Gene Therapy Capsid Decoys: The presence of an excess of empty AAV capsids may effectively absorb low-level neutralizing antibodies (NAbs) and non-NAbs, permitting transduction even in their presence.

Additional information

Serotype

, , , , , , , , , , , ,

Size

100ul, 200ul, 500ul, 1000ul

Please Login To Download Attachment